Global Methyl Methacrylate (MMA) Industry Report 2014

  • Methyl Methacrylate,MMA,Industry Report

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Methyl Methacrylate (MMA) Industry Report 2014" report to their offering.

The Global Methyl Methacrylate (MMA) Industry Report 2014 is a professional and in-depth study on the current state of the global methyl methacrylate industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The methyl methacrylate market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status..

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Methyl methacrylate industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on fourteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The methyl methacrylate industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 233 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Key Topics Covered:

Chapter One Methyl Methacrylate (MMA) Industry Overview

Chapter Two Global Methyl Methacrylate (MMA) Market Status Analysis

Chapter Three Major Regions Methyl Methacrylate (MMA) Market Status Analysis

Chapter Four Major Countries Methyl Methacrylate (MMA) Market Status and Analysis

Chapter Five Major Companies Methyl Methacrylate (MMA) Market Status and Analysis

Chapter Six Methyl Methacrylate (MMA) Industry Chain and Marketing Channels Analysis

Chapter Seven Methyl Methacrylate (MMA) Industry Segment Market Analysis

Chapter Eight Methyl Methacrylate (MMA) Industry Development Trend

Chapter Nine Methyl Methacrylate (MMA) New Project Investment Feasibility Analysis

Chapter Ten Global Methyl Methacrylate (MMA) Industry Research Conclusions

Companies Mentioned:


  • Arkema group

  • BASF

  • Dow

  • Evonik


  • Kuraray

  • Luciteinternational


  • Mitsubishi Rayon Polymer




  • Zmlxhg

This link:

The ChemCD compiler finishing, shall not be reproduced without permission, for reprint please indicate the source。

comments powered by Disqus


Related News

Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence.

Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sarilumab.

First data backs efficacy of BMS' novel HIV drug

A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.

EU Rules Could Restrict Genetic Testing

Genetic testing describes the application of laboratory methods to look at a person’s genes (the inherited DNA instructions). Genetic tests can be used to diagnose a genetic condition; screen for a risk of developing a particular health problems; for the selection of treatments; or to assess responses to treatments.

CHMP adopts positive opinion of Edurant in adolescents with HIV-1

The CHMP has adopted a positive opinion recommending a change to the terms of the marketing authorisation for Janssen’s Edurant (rilpivirine) in the EU to extend the indication to adolescent patients aged 12 to <18 years with human immunodeficiency virus-1 (HIV-1) infection

FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval

Neos Therapeutics got an ominous note from the FDA just weeks ahead of the expected approval date for its long-acting ADHD treatment, clouding the future of the company's lead asset.

Pfizer's once-failed cancer drug wins the FDA's 'breakthrough' tag

Pfizer has found new hope for a former pipeline standout, picking up the FDA's coveted breakthrough therapy designation for a Phase III reclamation project in oncology.